These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26253646)

  • 1. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients.
    Wang TY; Lee KD; Chen PT; Chen MC; Chen YY; Huang CE; Kuan FC; Chen CC; Lu CH
    J Formos Med Assoc; 2015 Nov; 114(11):1055-60. PubMed ID: 26253646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.
    Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C
    J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
    Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
    Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
    J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement.
    Song MG; Seo TS; Kang EY; Yong HS; Seo JH; Choi YY
    J Vasc Access; 2015; 16(4):315-20. PubMed ID: 25953212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
    Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
    J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
    Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
    Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of non-tunnelled central venous catheter-related infections in oncologic patients receiving chemotherapy in an outpatient setting.
    Madhukumar P; Loh GY; Maung ZA; Chua FS; Chen JJ
    Singapore Med J; 2012 Aug; 53(8):513-6. PubMed ID: 22941127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors.
    Touré A; Vanhems P; Lombard-Bohas C; Cassier P; Péré-Vergé D; Souquet JC; Ecochard R; Chambrier C
    Am J Infect Control; 2012 Dec; 40(10):935-9. PubMed ID: 22633131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.
    Hsu JF; Chang HL; Tsai MJ; Tsai YM; Lee YL; Chen PH; Fan WC; Su YC; Yang CJ
    World J Surg Oncol; 2015 Sep; 13():288. PubMed ID: 26420628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.
    Berardi R; Rinaldi S; Santini D; Vincenzi B; Giampieri R; Maccaroni E; Marcucci F; Francoletti M; Onofri A; Lucarelli A; Pierantoni C; Tonini G; Cascinu S
    Support Care Cancer; 2015 May; 23(5):1295-302. PubMed ID: 25326782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days.
    Cotogni P; Pittiruti M; Barbero C; Monge T; Palmo A; Boggio Bertinet D
    JPEN J Parenter Enteral Nutr; 2013; 37(3):375-83. PubMed ID: 23002096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained low incidence of central venous catheter-related infections over six years in a Swedish hospital with an active central venous catheter team.
    Hammarskjöld F; Berg S; Hanberger H; Taxbro K; Malmvall BE
    Am J Infect Control; 2014 Feb; 42(2):122-8. PubMed ID: 24485369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of infectious complications related to implantable venous-access ports.
    Shim J; Seo TS; Song MG; Cha IH; Kim JS; Choi CW; Seo JH; Oh SC
    Korean J Radiol; 2014; 15(4):494-500. PubMed ID: 25053910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.